EUVIMEDEUVIMED entdecken
Open Access

METTL3-mediated m6A modification of SLC7A11 enhances nasopharyngeal carcinoma radioresistance by inhibiting ferroptosis

Zili Dai, Baisheng Lin, Maohua Qin, Yunen Lin, Li Wang, Kai Liao, Guofeng Xie, Feixiang Wang, Jian Zhang

International Journal of Biological Sciences · 10.02.2025 · 21 (4) · 1837-1851

DOI: 10.7150/ijbs.100518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 10.02.2025. Verfasst von Zili Dai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou 510…. Hauptthemen laut MEDLINE: Ferroptosis, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Amino Acid Transport System y+. Die Arbeit wurde bisher 35-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy is the primary treatment for nasopharyngeal carcinoma (NPC); nonetheless, radioresistance remains the leading cause of localized recurrence. Our study demonstrates a significant increase in the N6-methyladenosine (m6A) methylase METTL3 in NPC and other tumors. Mechanistically, METTL3 acts as an m6A methylase, enhancing the m6A modification of the solute carrier family 7 member 11 (SLC7A11) transcript, which increases its stability and expression, thereby inhibiting radiation-induced ferroptosis and ultimately inducing radioresistance in NPC. Furthermore, silencing SLC7A11 or employing the ferroptosis inducer Erastin negated the promoting effect of METTL3 on NPC cell radioresistance. These findings suggest that METTL3 could be a novel therapeutic target for overcoming radiotherapy resistance in NPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisNasopharyngeal CarcinomaNasopharyngeal NeoplasmsAmino Acid Transport System y+MethyltransferasesRadiation ToleranceAdenosineHumansCell Line, TumorCarcinomaGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

SLC7A11ferroptosism6A modificationnasopharyngeal carcinomaradiosensitivity

Substanzen

SLC7A11 protein, humanAmino Acid Transport System y+MethyltransferasesMETTL3 protein, humanN-methyladenosineAdenosine

Autor:innen und Institutionen

  • Department of Radiation Oncology, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou 510095, China.
  • Department of pathology, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China.
  • Department of Thoracic Surgery, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China.

Zitieren

APA

Dai, Z., Lin, B., Qin, M., Lin, Y., Wang, L., Liao, K., Xie, G., Wang, F., & Zhang, J. (2025). METTL3-mediated m6A modification of SLC7A11 enhances nasopharyngeal carcinoma radioresistance by inhibiting ferroptosis. International Journal of Biological Sciences, 21(4), 1837-1851. https://doi.org/10.7150/ijbs.100518

Vancouver

Dai Z, Lin B, Qin M, Lin Y, Wang L, Liao K, et al. METTL3-mediated m6A modification of SLC7A11 enhances nasopharyngeal carcinoma radioresistance by inhibiting ferroptosis. International Journal of Biological Sciences. 2025;21(4):1837-1851. doi:10.7150/ijbs.100518

BibTeX
@article{Dai2025,
  author = {Dai, Zili and Lin, Baisheng and Qin, Maohua and Lin, Yunen and Wang, Li and Liao, Kai and Xie, Guofeng and Wang, Feixiang and Zhang, Jian},
  title = {METTL3-mediated m6A modification of SLC7A11 enhances nasopharyngeal carcinoma radioresistance by inhibiting ferroptosis},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  volume = {21},
  number = {4},
  pages = {1837--1851},
  doi = {10.7150/ijbs.100518}
}
Kostenlos starten →